BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liang J, Hänsch GM, Hübner K, Samstag Y. Sulforaphane as anticancer agent: A double-edged sword? Tricky balance between effects on tumor cells and immune cells. Adv Biol Regul 2019;71:79-87. [PMID: 30528536 DOI: 10.1016/j.jbior.2018.11.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Wang M, Pu D, Zhao Y, Chen J, Zhu S, Lu A, Liao Z, Sun Y, Xiao Q. Sulforaphane protects against skeletal muscle dysfunction in spontaneous type 2 diabetic db/db mice. Life Sci 2020;255:117823. [PMID: 32445760 DOI: 10.1016/j.lfs.2020.117823] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Bronisz-Budzyńska I, Kozakowska M, Podkalicka P, Kachamakova-Trojanowska N, Łoboda A, Dulak J. The role of Nrf2 in acute and chronic muscle injury. Skelet Muscle 2020;10:35. [PMID: 33287890 DOI: 10.1186/s13395-020-00255-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kamal MM, Akter S, Lin CN, Nazzal S. Sulforaphane as an anticancer molecule: mechanisms of action, synergistic effects, enhancement of drug safety, and delivery systems.Arch Pharm Res. 2020;43:371-384. [PMID: 32152852 DOI: 10.1007/s12272-020-01225-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
4 Amintas S, Dupin C, Boutin J, Beaumont P, Moreau-Gaudry F, Bedel A, Krisa S, Vendrely V, Dabernat S. Bioactive food components for colorectal cancer prevention and treatment: A good match. Crit Rev Food Sci Nutr 2022;:1-15. [PMID: 35128990 DOI: 10.1080/10408398.2022.2036095] [Reference Citation Analysis]
5 Chun KS, Kim DH, Raut PK, Surh YJ. Anticancer natural products targeting immune checkpoint protein network. Semin Cancer Biol 2021:S1044-579X(21)00279-0. [PMID: 34838956 DOI: 10.1016/j.semcancer.2021.11.006] [Reference Citation Analysis]
6 Surh Y. Nrf2 paradox: Can cancer patients eat broccoli? Food Frontiers 2021;2:25-8. [DOI: 10.1002/fft2.61] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bailly C. Regulation of PD-L1 expression on cancer cells with ROS-modulating drugs. Life Sciences 2020;246:117403. [DOI: 10.1016/j.lfs.2020.117403] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
8 Choudhury FK, Hackman GL, Lodi A, Tiziani S. Stable Isotope Tracing Metabolomics to Investigate the Metabolic Activity of Bioactive Compounds for Cancer Prevention and Treatment. Cancers (Basel) 2020;12:E2147. [PMID: 32756373 DOI: 10.3390/cancers12082147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Xie H, Chun FK, Rutz J, Blaheta RA. Sulforaphane Impact on Reactive Oxygen Species (ROS) in Bladder Carcinoma. Int J Mol Sci 2021;22:5938. [PMID: 34073079 DOI: 10.3390/ijms22115938] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Boo YC. Natural Nrf2 Modulators for Skin Protection. Antioxidants (Basel) 2020;9:E812. [PMID: 32882952 DOI: 10.3390/antiox9090812] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
11 Wang Y, Petrikova E, Gross W, Sticht C, Gretz N, Herr I, Karakhanova S. Sulforaphane Promotes Dendritic Cell Stimulatory Capacity Through Modulation of Regulatory Molecules, JAK/STAT3- and MicroRNA-Signaling. Front Immunol 2020;11:589818. [PMID: 33193420 DOI: 10.3389/fimmu.2020.589818] [Reference Citation Analysis]
12 Mahn A, Castillo A. Potential of Sulforaphane as a Natural Immune System Enhancer: A Review. Molecules 2021;26:752. [PMID: 33535560 DOI: 10.3390/molecules26030752] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Lastra D, Fernández-Ginés R, Manda G, Cuadrado A. Perspectives on the Clinical Development of NRF2-Targeting Drugs. Handb Exp Pharmacol 2021;264:93-141. [PMID: 32776282 DOI: 10.1007/164_2020_381] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Zhu M, Han W, Ling Y, Qi Q, Zhang Y, Peng Y, Chen L, Bao Y, Liu Y. Preliminary Study on the In Vitro Antitumor Effects of Nidus Vespae on Gastric Cancer. Evid Based Complement Alternat Med 2021;2021:1549359. [PMID: 34194516 DOI: 10.1155/2021/1549359] [Reference Citation Analysis]
15 Muñoz M, Rosso M, Coveñas R. Triple Negative Breast Cancer: How Neurokinin-1 Receptor Antagonists Could Be Used as a New Therapeutic Approach. Mini Rev Med Chem 2020;20:408-17. [PMID: 31721701 DOI: 10.2174/1389557519666191112152642] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Panieri E, Buha A, Telkoparan-Akillilar P, Cevik D, Kouretas D, Veskoukis A, Skaperda Z, Tsatsakis A, Wallace D, Suzen S, Saso L. Potential Applications of NRF2 Modulators in Cancer Therapy. Antioxidants (Basel) 2020;9:E193. [PMID: 32106613 DOI: 10.3390/antiox9030193] [Cited by in F6Publishing: 41] [Reference Citation Analysis]
17 Aishworiya R, Valica T, Hagerman R, Restrepo B. An Update on Psychopharmacological Treatment of Autism Spectrum Disorder. Neurotherapeutics 2022. [PMID: 35029811 DOI: 10.1007/s13311-022-01183-1] [Reference Citation Analysis]
18 Singh KB, Hahm ER, Alumkal JJ, Foley LM, Hitchens TK, Shiva SS, Parikh RA, Jacobs BL, Singh SV. Reversal of the Warburg phenomenon in chemoprevention of prostate cancer by sulforaphane. Carcinogenesis 2019;40:1545-56. [PMID: 31555797 DOI: 10.1093/carcin/bgz155] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
19 Jabbarzadeh Kaboli P, Afzalipour Khoshkbejari M, Mohammadi M, Abiri A, Mokhtarian R, Vazifemand R, Amanollahi S, Yazdi Sani S, Li M, Zhao Y, Wu X, Shen J, Cho CH, Xiao Z. Targets and mechanisms of sulforaphane derivatives obtained from cruciferous plants with special focus on breast cancer - contradictory effects and future perspectives. Biomed Pharmacother 2020;121:109635. [PMID: 31739165 DOI: 10.1016/j.biopha.2019.109635] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
20 Wigner P, Bijak M, Saluk-Bijak J. The Green Anti-Cancer Weapon. The Role of Natural Compounds in Bladder Cancer Treatment. Int J Mol Sci 2021;22:7787. [PMID: 34360552 DOI: 10.3390/ijms22157787] [Reference Citation Analysis]
21 Das PK, Zahan T, Abdur Rakib M, Khanam JA, Pillai S, Islam F. Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy. Anticancer Agents Med Chem 2019;19:1796-808. [PMID: 31272363 DOI: 10.2174/1871520619666190704111714] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Mastuo T, Miyata Y, Yuno T, Mukae Y, Otsubo A, Mitsunari K, Ohba K, Sakai H. Molecular Mechanisms of the Anti-Cancer Effects of Isothiocyanates from Cruciferous Vegetables in Bladder Cancer. Molecules 2020;25:E575. [PMID: 32013065 DOI: 10.3390/molecules25030575] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
23 Shen C, Zhang Z, Tian Y, Li F, Zhou L, Jiang W, Yang L, Zhang B, Wang L, Zhang Y. Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway. BMC Med 2021;19:283. [PMID: 34819055 DOI: 10.1186/s12916-021-02161-8] [Reference Citation Analysis]
24 Li S, Xu Z, Alrobaian M, Afzal O, Kazmi I, Almalki WH, Altamimi ASA, Al-Abbasi FA, Alharbi KS, Altowayan WM, Singh T, Akhter MH, Gupta M, Rahman M, Beg S. EGF-functionalized lipid-polymer hybrid nanoparticles of 5-fluorouracil and sulforaphane with enhanced bioavailability and anticancer activity against colon carcinoma. Biotechnol Appl Biochem 2021. [PMID: 34775646 DOI: 10.1002/bab.2279] [Reference Citation Analysis]